Experience With Moxifloxacin for the Treatment of Latent Tuberculosis Infection in Liver Transplantation: A Single-Center Prospective Study

Liver Transpl. 2021 Jun;27(6):913-917. doi: 10.1002/lt.25961. Epub 2021 Mar 5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Humans
  • Latent Tuberculosis* / diagnosis
  • Latent Tuberculosis* / drug therapy
  • Liver Transplantation* / adverse effects
  • Moxifloxacin / therapeutic use
  • Mycobacterium tuberculosis*
  • Prospective Studies

Substances

  • Antitubercular Agents
  • Moxifloxacin